| Battle Mountain General Hospital | |
| 535 S. Humboldt Street, Battle Mountain, Nevada 89820 | |
| (775) 635-2550 | |
| Name | Battle Mountain General Hospital |
|---|---|
| Location | 535 S. Humboldt Street, Battle Mountain, Nevada |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 25 |
| Occupancy Rate | 86.4% |
| Medicare ID (CCN) | 295063 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | Government - Hospital District |
| NPI Number | 1366658809 |
| Organization Name | BATTLE MOUNTAIN GENERAL HOSPITAL |
| Address | 535 S Humboldt St, Battle Mountain, NV 89820 |
| Phone Number | 775-635-2550 |
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.
A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center reported.
Following gene therapy, the retina can restructure itself and regain normal light responses, according to research in mice published in JNeurosci.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.
A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center reported.
Following gene therapy, the retina can restructure itself and regain normal light responses, according to research in mice published in JNeurosci.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.22 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 7.5 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 21.46 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.18 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.88 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 0 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.87 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 36.59 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 21.62 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 0 | 82.93 |
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.
A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center reported.
Following gene therapy, the retina can restructure itself and regain normal light responses, according to research in mice published in JNeurosci.
› Verified 8 days ago
Battle Mountain General Hospital Location: 535 S. Humboldt Street, Battle Mountain, Nevada 89820 Phone: (775) 635-2550 |